Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy
- PMID: 29926735
- DOI: 10.1089/AID.2017.0316
Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy
Abstract
A recent infection testing algorithm (RITA) that includes a test for recent HIV infection and a viral load (VL) test is the recommended strategy to estimate national HIV incidence, reducing false-recent misclassification to <1%. The inclusion of information on exposure to antiretroviral therapy (ART), as a supplement to VL testing, could improve RITA performance by further lowering false-recent misclassification of true long-term infection. In 2012, Kenya and South Africa conducted national population-based surveys that collected information on HIV recency (i.e., HIV antibody seroconversion, on average, in the past 130 days) using the Limiting Antigen avidity (LAg-Avidity) enzyme immunoassay, HIV RNA levels, and ART exposure among HIV-infected respondents aged 15-49 years. In Kenya, ART exposure was defined as testing positive for one or more antiretroviral (ARV) drugs using high-performance liquid chromatography coupled with tandem mass spectrometry, and, if not ARV-positive, self-reporting a history of ART exposure. In South Africa, ART exposure was defined as testing ARV-positive. Two RITA strategies were compared: RITA #1 defined recent infection as testing LAg-Avidity-recent with unsuppressed VL (HIV RNA ≥1,000 copies/ml), and RITA #2 defined recent infection as testing LAg-Avidity-recent with unsuppressed VL and, if unsuppressed, having no ART exposure. RITA-derived incidence among persons aged 15-49 years in Kenya was 0.9% on RITA #1 and 0.8% on RITA #2. In South Africa, RITA-derived incidence was 2.2% on RITA #1 and 1.7% on RITA #2. Among specimens testing recent with unsuppressed VL in Kenya and South Africa, 16.0% and 19.7% had evidence of ART exposure, respectively. Although the performance of a VL- and ART-based RITA was encouraging, additional research is needed across HIV-1 subtypes and subpopulations to calibrate and validate this algorithm.
Keywords: HIV incidence; Limiting Antigen avidity enzyme immunoassay; national population-based survey; recent infection testing algorithm; sub-Saharan Africa.
Similar articles
-
HIV-1 Recent Infection Testing Algorithm With Antiretroviral Drug Detection to Improve Accuracy of Incidence Estimates.J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S73-S80. doi: 10.1097/QAI.0000000000002707. J Acquir Immune Defic Syndr. 2021. PMID: 34166315 Free PMC article.
-
A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.BMC Infect Dis. 2017 Sep 29;17(1):653. doi: 10.1186/s12879-017-2740-y. BMC Infect Dis. 2017. PMID: 28969607 Free PMC article.
-
Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.Int J STD AIDS. 2018 May;29(6):603-610. doi: 10.1177/0956462417748859. Epub 2018 Jan 16. Int J STD AIDS. 2018. PMID: 29334886 Free PMC article.
-
HIV misdiagnosis in sub-Saharan Africa: performance of diagnostic algorithms at six testing sites.J Int AIDS Soc. 2017 Jul 3;20(1):21419. doi: 10.7448/IAS.20.1.21419. J Int AIDS Soc. 2017. PMID: 28691437 Free PMC article. Review.
-
Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials.Curr HIV/AIDS Rep. 2020 Jun;17(3):249-258. doi: 10.1007/s11904-020-00492-4. Curr HIV/AIDS Rep. 2020. PMID: 32297219 Free PMC article. Review.
Cited by
-
Can HIV recent infection surveillance help us better understand where primary prevention efforts should be targeted? Results of three pilots integrating a recent infection testing algorithm into routine programme activities in Kenya and Zimbabwe.J Int AIDS Soc. 2020 Jun;23 Suppl 3(Suppl 3):e25513. doi: 10.1002/jia2.25513. J Int AIDS Soc. 2020. PMID: 32602625 Free PMC article.
-
Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.PLoS One. 2019 Sep 16;14(9):e0222290. doi: 10.1371/journal.pone.0222290. eCollection 2019. PLoS One. 2019. PMID: 31525218 Free PMC article.
-
Evaluation of the HIV-1 Rapid Recency Assay and Limiting Antigen Avidity Enzyme Immunoassay for HIV Infection Status Interpretation in Long-Term Diagnosed Individuals in Thailand.Diagnostics (Basel). 2025 Feb 12;15(4):444. doi: 10.3390/diagnostics15040444. Diagnostics (Basel). 2025. PMID: 40002595 Free PMC article.
-
Impact of Early Antiretroviral Treatment Initiation on Performance of Cross-Sectional Incidence Assays.AIDS Res Hum Retroviruses. 2020 Jul;36(7):583-589. doi: 10.1089/AID.2019.0286. Epub 2020 May 27. AIDS Res Hum Retroviruses. 2020. PMID: 32295382 Free PMC article.
-
Microdrop Human Immunodeficiency Virus Sequencing for Incidence and Drug Resistance Surveillance.J Infect Dis. 2021 Sep 17;224(6):1048-1059. doi: 10.1093/infdis/jiab060. J Infect Dis. 2021. PMID: 33517458 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous